Stem cells are being used to develop robust, reliable disease models that are advancing our understanding of underlying disease progression and mechanism.  Stem…

How are stem cells advancing compound screening and analysis of drug-like properties? Stem cells are emerging as significant reagents in drug development pipelines. …

Advances in Culturing Stem Cells Stem cells may hold the answer to one of the biggest medical challenges, replacing tissues and organs.  Exciting…

Core labs at academic institutes lower the barrier to expensive technology and give people access to techniques outside their field of expertise. These…

Researchers and pharmaceutical companies believe that stem cells, especially induced pluripotent stem cells (iPSC), hold great promise for drug discovery. There is a…

Making stem cells from terminally differentiated cells is still relatively new technology. Shinya Yamanaka first described the technique in a 2006 publication, and labs across the world now use his basic principle of turning back the clock on cells through the introduction of transcription factors. There are a lot of questions biomedical researchers and pharmaceutical companies can address using iPS cells to model disease. But what if you are not a stem cell specialist?

Last week we talked about Stem cell research getting the “green light” and this week we continue with our stem cell blog series. Biology…

One of Assay Depot’s most popular blog posts of last year was an infographic depicting American attitudes towards stem cell research.  Part of…

Stem Cells have been a topic of controversy for years. They provide a unique opportunity to address humanity’s worst diseases yet derive mostly from…